跳至主要内容
临床试验/NCT04088383
NCT04088383
已完成
不适用

A Prospective, Randomized, Double Blind Investigation of Amnios™ RT for the Treatment of Plantar Fasciitis

Globus Medical Inc1 个研究点 分布在 1 个国家目标入组 150 人2019年9月10日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Plantar Fasciitis
发起方
Globus Medical Inc
入组人数
150
试验地点
1
主要终点
Serious Adverse Events
状态
已完成
最后更新
3年前

概览

简要总结

The purpose of this study is to evaluate clinical outcomes of patients with plantar fasciitis following treatment with Amnios™ RT. Patients will be randomized to either Amnios™ RT or a placebo control.

注册库
clinicaltrials.gov
开始日期
2019年9月10日
结束日期
2022年11月30日
最后更新
3年前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Confirmed diagnosis of unilateral plantar fasciitis for ≥ 1 month (30 days) and ≤ 18 months by the Investigator
  • VAS Foot Pain score of at least 45mm (out of 100mm scale) at randomization
  • Plantar fasciitis with conservative treatment for ≥ 1 month (30 days), including any of the following modalities:
  • Stretching exercises
  • Orthotics
  • Diagnostic radiograph within 6 months of enrollment showing view of calcaneus, without evidence of calcaneal fracture or structural abnormalities
  • BMI ≤ 40 kg/m2
  • Age ≥ 18 years and \< 80 years
  • Willing and able to comply with the follow-up requirements of the protocol
  • Signed an Informed Consent Form specific to this research and agreed to release of medical information

排除标准

  • Prior surgery or trauma resulting in severe, permanent damage to the affected foot
  • Require bilateral plantar fasciitis treatment at time of enrollment (with exception of compensatory symptoms on the non-affected foot)
  • Prior use of any lower limb injection therapy, including corticosteroids or PRP in either foot within the last 3 months
  • Has Type I or Type II diabetes mellitus
  • Systemic disorders associated with enthesopathy (disorder of entheses, i.e. bone attachments) such as Gout, reactive arthritis, rheumatoid arthritis, etc.
  • The presence of diagnosed comorbidities that can be confused with or can exacerbate the condition (as assessed by radiograph) including:
  • Calcaneal stress fracture
  • Nerve entrapment syndrome (diagnosed as Baxter Nerve Syndrome)
  • Fat pad atrophy (relative to expectations for patient's age)
  • Acute traumatic rupture of the plantar fascia

结局指标

主要结局

Serious Adverse Events

时间窗: 12 Months

The occurrence of serious adverse events that are related to the product.

Visual Analog Scale (VAS) Foot Pain Score

时间窗: 3 Months

The visual analog scale (VAS) is a patient questionnaire used to quantify a subjective experience, such as the intensity of pain. The scale is a 100mm line labeled with "no pain" on the left border and "most intense pain imaginable" on the right border. The subject is instructed to place a vertical line on the scale that indicates the pain severity experienced; 0mm is equal to no pain and 100mm is most intense pain imaginable. Study staff records the distance of the patient's mark on the scale in millimeters.

研究点 (1)

Loading locations...

相似试验